A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...

The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the industry has three strong pillars: very pro active...

The pharmaceutical industry is expanding worldwide. For some years now, it has been benefiting from the particular dynamics of the Asian economies as both purchasers and producers. It is not only the markets in China and India that register high growth rates. Despite the positive outlook India...

Three important aspects of the Canadian pharmaceutical industry-viz. compulsory licence, price control on patented drugs and the R&D scenario. Unlike other developed countries, which have adopted the route of providing higher Intellectual Property Rights (IPR) protection to promote the growth of...

This paper uses aggregate and firm level data to examine the characteristics of the Chinese pharmaceutical industry in general and its geographical agglomeration in particular. It addresses the following research questions: 1) Are there geographical agglomerations in China’s...

This paper investigates the effects of plants' dynamics on productivity growth in the Indian pharmaceutical industry across five regions: north, north-west, west, south and the rest of India, during the period from 2000-01 to 2005-06, using the unit-level panel database drawn from the Annual...

The relationship between health professionals and the pharmaceutical industry has become a source of controversy. Physicians’ attitudes towards the industry can form early in their careers, but little is known about this key stage of development. A search in MEDLINE, EMBASE, Web of...

Budget expectations from various sectors are given. URL:[ http://www.myiris.com/newsCentre/storyShow.php?fileR=20110217120638043&secID=fromnewsroom&secTitle=From the News Room&dir=2011/02/17].

Poor quality essential medicines, both substandard and counterfeit, are serious but neglected public health problems. Anti-infective medicines are particularly afflicted. Unfortunately, attempts to improve medicine quality have been hampered by confusion and controversy over definitions. For...